About Fermelanta
Fermelanta is a company based in Nonoichi (Japan) founded in 2022 by Hiromichi Minami, Akira Nakagawa, and Shogo Fukizaki. Fermelanta has raised $21.43 million across 3 funding rounds from investors including Plug and Play Tech Center, Beyond Next Ventures and Keio Innovation Initiative. Fermelanta operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Nonoichi, Japan
- Founders Hiromichi Minami, Akira Nakagawa, Shogo Fukizaki
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$21.43 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Plug and Play Tech Center
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Fermelanta
Fermelanta has successfully raised a total of $21.43M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fermelanta
Fermelanta has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Plug and Play Tech Center, Beyond Next Ventures and Keio Innovation Initiative.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in innovative startups by Angel Bridge.
|
Locked | Locked | Locked | |
|
Startups are accelerated and invested in across multiple tech sectors.
|
Locked | Locked | Locked |
Investor details for Fermelanta
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fermelanta
Investment portfolio details for Fermelanta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fermelanta
Detailed financials for Fermelanta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fermelanta Comparisons
Peer comparison for Fermelanta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fermelanta
Fermelanta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Detailed competitors of Fermelanta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fermelanta
Complete news archive for Fermelanta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fermelanta
Fermelanta was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Fermelanta is headquartered in Nonoichi, Japan. It is registered at Nonoichi, Ishikawa, Japan.
Shogo Fukizaki is the current CEO of Fermelanta. They have also founded this company.
Fermelanta is a funded company, having raised a total of $21.43M across 3 funding rounds to date.
Fermelanta was founded in 2022 in Nonoichi, Japan, as a biotech firm. Microbial fermentation processes are employed to generate plant-based chemicals, with a focus on secondary metabolites. These compounds are applied in medicines, cosmetics, and health foods. Operations center on sustainable production methods within the biotechnology sector, supporting various industrial applications.
Fermelanta has 10 investors. Key investors include Plug and Play Tech Center, Beyond Next Ventures, Keio Innovation Initiative, Angel Bridge, and SMBC Venture Capital.